Highlights
About
Tumor Biomarker Technologies for Early Cancer Diagnosis
BioMarCare uses a multi-biomarker panel approach to generate molecular blood tests andtissue-based diagnostic (IHC) tests with high specificity and sensitivity for use in the early diagnosis of cancer. The companys Colon-MarCarePlex is an accurate, patient-friendly colorectal cancer screening test that measures the expression of several genes thatserve as biomarkers to detect colorectal cancer. It offers fast, affordable results with no bowel preparation, no diet or medication restrictions, and no handling of stool. Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early-stage colorectal cancer. BioMarCares MCRC-Strat is a semi-quantitative IHC assay using a protein biomarker combination designed to predict patient responses to drugs targeting the epidermal growth factor receptor. The product is being developed in collaboration with a U.S. partner.
Identity
| Name | BioMarCare |
|---|---|
| Slug | biomarcare |
| Type / kind | startup |
| Crunchbase ID | biomarcare-technologies |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6fmZ0LDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Aug 2020 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Ein Karem, Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/988311 |
Classifications
Funding
| Total raised | $1.9M |
|---|---|
| Current stage | Mature |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}